The Newshound

More than 20,000 NHS patients with bloating and stomach pain will be offered a blood test that could catch 13 cancers

An NHS Blood and Transplant unit like those that will support the STRIDE-RCT trial, which aims to determine whether multi-cancer blood tests are reliable enough for broader deployment across the health service.
An NHS Blood and Transplant unit like those that will support the STRIDE-RCT trial, which aims to determine whether multi-cancer blood tests are reliable enough for broader deployment across the health service.

The £8.5m STRIDE-RCT trial, led by the University of Birmingham and backed by the government, will recruit over-45s at more than 200 GP surgeries across England. Each test analyses a single blood sample for tumour-shed DNA fragments and cancer-linked proteins, with AI used to identify the likely location in the body where a cancer may be developing.

Health Secretary Yvette Cooper said: 'The earlier cancers are diagnosed, the more chance they can be successfully treated, and lives can be saved.'

Three different tests from separate companies will be compared — including Enlighten, developed by UK biotech firm Proteotype Diagnostics.

Around 35,000 people in England die every year from the abdominal cancers the trial targets, which are often caught only after they have spread.

MoreYahoo News UKNHS to trial blood tests that detect multiple cancersLBCNew NHS blood test trial could help detect cancers earlierBBC News'Multi-cancer' blood tests coming to some GP surgeries soonThe TimesGP patients to be offered new blood test for 13 types of cancerTimes NowCan a routine blood test help detect 13 cancers? Here's what the UK NHS is testingmirror.co.ukNHS trials first multi-cancer blood test to investigate common symptoms often dismissed - The MirrorHealth and MeBowel, Pancreatic & Liver: NHS Trial Offers New Blood Test To 20,000 Patients That Could Detect 13 Cancers - Health and Me
Read today's full feed at The Newshound →